Back
GSK PLC 10K Form
Sell
22
GSK
GSK PLC
Last Price:
33.31
Seasonality Move:
5.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GSK News And Ratings
See the #1 stock for the next 7 days that we like better than GSK
GSK Financial Statistics
Sales & Book Value
| Annual Sales: | $37.74B |
|---|---|
| Cash Flow: | $1.75B |
| Price / Cash Flow: | 11.48 |
| Annual Sales: | $9.19 |
| Price / Book: | 3.67 |
Profitability
| EPS (TTM): | 1.53820 |
|---|---|
| Net Income (TTM): | $3.17B |
| Gross Margin: | $27.08B |
| Return on Equity: | 18.89% |
| Return on Assets: | 4.23% |
GSK PLC Earnings Forecast
Key GSK PLC Financial Ratios
- The Gross Profit Margin over the past 29 years for GSK is 71.76%.
- The Selling, General & Administrative Expenses for GSK have been equal to 30.95% of Gross Profit Margin.
- The Research & Development expenses have been 20.52% of Revenue.
- The Interest Expense is 14.71% of Operating Income.
- The Net Earning history of GSK is 16.25% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 23 years.
GSK PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | GSK |
| CUSIP: | 37733W |
| Website: | gsk.com |
Debt
| Debt-to-Equity Ratio: | 1.15 |
|---|---|
| Current Ratio: | 0.81 |
| Quick Ratio: | 0.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.29 |
|---|---|
| Forward P/E Ratio: | 7.87 |